Denosumab in the prevention of immobilization-induced bone loss in Intensive Care Unit patients
Latest Information Update: 12 Dec 2022
At a glance
- Drugs Denosumab (Primary)
- Indications Bone resorption
- Focus Pharmacodynamics; Therapeutic Use
Most Recent Events
- 01 Nov 2022 Primary endpoint has been met, (a) Serum levels of carboxy-terminal collagen crosslinks (CTX-1) one month after first denosumab application, as per Results published in the Journal of Bone and Mineral Research
- 01 Nov 2022 Results published in the Journal of Bone and Mineral Research
- 24 Jul 2022 Status changed from recruiting to completed.